Analysis of correlation between T cell subsets and disease severity and poor clinical outcome in patients with ulcerative colitis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200065103

Enrollment

Unknown

Registered

2022-10-27

Start date

2022-10-31

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

Disease group:None

Control group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients were diagnosed as ulcerative colitis by clinical manifestations, laboratory indexes, endoscopic manifestations and pathology; 2. Patients agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors ; 2. Patients with severe heart, liver, lung and renal insufficiency ; 3. Patients with other autoimmune diseases.

Design outcomes

Primary

Measure	Time frame
T cell subsets;	—

Countries

China

Contacts

Public ContactTian zibin

The Affiliated Hospital of Qingdao University

tianzb@qdu.edu.cn+86 18661805123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026